|
Founded in
June 2001 and based in
Taipei,
A-Spine Asia (ASA) is an emerging medical device company
dedicated to the research, development, manufacturing
and marketing of spinal implants and instruments for
better spine health management.
In addition to its leading position
in Taiwanese spinal implant market, Asia’s products are
now commercially available in 17 countries worldwide
including China, South Korea, the Philippines,
Singapore, Thailand, Australia/New Zealand, India, Iran,
Greece, Turkey, Belgium, Spain, Germany, Trinidad and
USA.
ASA has a well-trained and highly motivated management
team with extensive experience in orthopedic and spine
medical devices.
Milestones：
|
Year
|
Description
|
|
2001
|
Founded and GMP plant
construction began in
NeiHu
Technology
Park,
Taipei.
|
|
2002
|
Company re-structured by
President Life Sciences
Co., Ltd.
|
|
2003
|
Passed plant site
inspection and received
cGMP Certificate from
Dept. of Health (DOH),
Executive Yuan,
Taiwan.
|
|
2004
|
ISO9001
&13485
and CE Marking approvals
for spinal fixation,
metal disc spacers,
polymer disc spacers and
instruments for spine
surgeries.
|
|
2005
|
Received 2 Taipei
Biotech Awards：Innovative
Technology (for
Vessel-X®) and
Technology
Commercialization (for
Spinal Fixation Systems)；
Launch
of interbody fusion
cages made from
PEEK-Optima® Invibio.
|
|
2006
|
Received Taipei Biotech
Award：Technology
commercialization (PEEK
cages)；
Signed Exclusive
Distribution Agreement
with ulrich Medical,
Germany for the spinal
products, and with
Biocomposites, UK for
bone graft products in
Taiwan market.
|
|
2007
|
Vessel-X® received
Taipei Biotech Award for
Technology
Commercialization；
Subsidiary company
Jiezhan Medical (Xiamen)
Co., Ltd. established in
Xiamen,
Fujian
Province,
China.
|
|
2008
|
Signed Partnership
Agreement with ulrich
Medical,
Germany.
|
|
2009
|
Signed Agreement with
TRB CHEMEDICA,
Switzerland
for the exclusive
distribution of sodium
hyaluronate preparation
Viscoseal® in
Taiwan;
Received “Partnership
Award 2009”from
ulrich
Medical,
Germany.
|
|
2010
|
Entering VCF market in
Taiwan
with Vessel-X®.
|
|
2011
|
Reorganizing of the
Board of Directors with
management buyout；
Dr. Por Lai was elected
as Chairman；
Received FDA 510(k)
clearance for Smartloc®
Advanced Spinal Fixation
System；
Signed Distribution
Agreement with Chindex
Medical Ltd.(Shanghai)
to exclusively
distribute ASA’s spinal
products in
China.
|
|
2012
|
Launch of Avalon®
Kyphoplasty Kit (for
export only)；
Launch of Viscoseal® in
Taiwan.
|
| 
